Dental Implant Therapy in Patients With Autoimmune Diseases: A Scoping Review
ABSTRACT Objectives The aim of this scoping review is to determine the effects of autoimmune diseases (ADs) and the agents used for treatment on dental implant survival and biologic outcomes. Material and Methods An electronic database search was performed in MEDLINE (PubMed), The Cochrane Library, and Embase on 29‐04‐2024.
Emil Hyldahl+2 more
wiley +1 more source
Evaluation of the Effectiveness of Using LED Light Combined With Chromophore Gel in Treating Acne Vulgaris - Preliminary Study. [PDF]
Deda AE+2 more
europepmc +1 more source
Stratum Corneum Interleukin‐2 in Facial Eczema at 1‐Month‐Old Predicts Later Atopic Dermatitis
Allergy, EarlyView.
Eriko Maehara+14 more
wiley +1 more source
An evaluation of important plant areas around the world
Abstract Area‐based approaches have long dominated biodiversity conservation and have been reinforced by the Kunming–Montreal Global Biodiversity Framework. The important plant area (IPA) approach is a leading framework for the spatial conservation prioritization of plants and fungi, but over 20 years since its launch, its application and conservation ...
Laura Kor+4 more
wiley +1 more source
Point-of-Care Ultrasound (POCUS) for Precision Management in Ellanse-Treated Patients. [PDF]
Wu L, Salti G, Cotofana S, Vercesi F.
europepmc +1 more source
Pleomorphic Adenoma of the Cheek : Report of a Case
Hideo Kurokawa+5 more
openalex +2 more sources
Risk Factors for Ectropion After Lower Eyelid and Cheek Reconstruction Following Mohs Micrographic Surgery. [PDF]
Rames JD+8 more
europepmc +1 more source
A case report of neurilemmoma occurring in the region from the cheek to the pterygopalatine fossa
Noboru Hayashi+7 more
openalex +2 more sources
Social‐benefits stigma and subsequent competitiveness
Abstract We conduct a laboratory experiment to explore how benefit‐eligibility stigma drives subsequent decisions to enter competition. We induce a stigma associated with a low‐status benefit and then introduce “plausible deniability” to reduce this stigma by expanding benefit eligibility to a middle‐status group.
Natalia I. Valdez Gonzalez+2 more
wiley +1 more source